Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feiyan Mo

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral VectorsFeiyan Mo, Maksim Mamonkin
Frontiers in Immunology|May 2, 2022
Impact of Manufacturing Procedures on CAR T Cell FunctionalityNorihiro Watanabe, Feiyan Mo, Mary Kathryn McKenna
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2020
CRISPR-Edited Immune Effectors: The End of the BeginningFeiyan Mo, Helen E Heslop, Maksim Mamonkin
Trends in Immunology|February 4, 2021
Taking T-Cell Oncotherapy Off-the-ShelfFeiyan Mo, Maksim Mamonkin, Malcolm K Brenner, et al.
Transplantation and Cellular Therapy|January 2, 2023
Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell TherapyJay A Read, Rayne H Rouce, Feiyan Mo, et al.
Antiviral Research|July 8, 2018
Repurposing potential of 1st generation H<sub>1</sub>-specific antihistamines as anti-filovirus therapeuticsAdam Schafer, Han Cheng, Rui Xiong, et al.
Cytotherapy|March 20, 2024
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosisFeiyan Mo, Chiou-Tsun Tsai, Rong Zheng, et al.
Cancer Immunology Research|October 29, 2017
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell MalignanciesMaksim Mamonkin, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid LeukemiaDiogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral VectorsFeiyan Mo, Maksim Mamonkin
Frontiers in Immunology|May 2, 2022
Impact of Manufacturing Procedures on CAR T Cell FunctionalityNorihiro Watanabe, Feiyan Mo, Mary Kathryn McKenna
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 24, 2020
CRISPR-Edited Immune Effectors: The End of the BeginningFeiyan Mo, Helen E Heslop, Maksim Mamonkin
Trends in Immunology|February 4, 2021
Taking T-Cell Oncotherapy Off-the-ShelfFeiyan Mo, Maksim Mamonkin, Malcolm K Brenner, et al.
Transplantation and Cellular Therapy|January 2, 2023
Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell TherapyJay A Read, Rayne H Rouce, Feiyan Mo, et al.
Antiviral Research|July 8, 2018
Repurposing potential of 1st generation H<sub>1</sub>-specific antihistamines as anti-filovirus therapeuticsAdam Schafer, Han Cheng, Rui Xiong, et al.
Cytotherapy|March 20, 2024
Human platelet lysate enhances in vivo activity of CAR-Vδ2 T cells by reducing cellular senescence and apoptosisFeiyan Mo, Chiou-Tsun Tsai, Rong Zheng, et al.
Cancer Immunology Research|October 29, 2017
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell MalignanciesMaksim Mamonkin, Malini Mukherjee, Madhuwanti Srinivasan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 5, 2018
CD7 CAR T Cells for the Therapy of Acute Myeloid LeukemiaDiogo Gomes-Silva, Erden Atilla, Pinar Ataca Atilla, et al.
Journal for Immunotherapy of Cancer|September 17, 2020
Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemiaPinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, et al.
Pageof 2